Fuchinoue S - Search Results

1

Successful A1-to-O ABO-incompatible kidney transplantation after a preconditioning regimen consisting of anti-CD20 monoclonal antibody infusions, splenectomy, and double-filtration plasmapheresis.

Sawada T, Fuchinoue S, Teraoka S. Sawada T, et al. Among authors: fuchinoue s. Transplantation. 2002 Nov 15;74(9):1207-10. doi: 10.1097/00007890-200211150-00001. Transplantation. 2002. PMID: 12451255

2

Kidney transplantation after liver transplantation from the same donor: four cases of successful steroid withdrawal.

Fuchinoue S, Sawada T, Tsuji K, Kai K, Tojimbara T, Nakajima I, Shiraga H, Ito K, Teraoka S. Fuchinoue S, et al. Transplantation. 2002 Mar 27;73(6):948-52. doi: 10.1097/00007890-200203270-00021. Transplantation. 2002. PMID: 11923698

3

Immunization by blood-type antigen in human immunoglobulin products before ABO-incompatible kidney transplantation.

Sawada T, Ando T, Sato S, Kubota K, Fuchinoue S, Teraoka S. Sawada T, et al. Among authors: fuchinoue s. Clin Transplant. 2004 Apr;18(2):219-21. doi: 10.1046/j.1399-0012.2003.00144.x. Clin Transplant. 2004. PMID: 15016140

4

Preconditioning regimen consisting of anti-CD20 monoclonal antibody infusions, splenectomy and DFPP-enabled non-responders to undergo ABO-incompatible kidney transplantation.

Sawada T, Fuchinoue S, Kawase T, Kubota K, Teraoka S. Sawada T, et al. Among authors: fuchinoue s. Clin Transplant. 2004 Jun;18(3):254-60. doi: 10.1111/j.1399-0012.2004.00151.x. Clin Transplant. 2004. PMID: 15142045

5

The 5-year outcome of ABO-incompatible kidney transplantation with rituximab induction.

Fuchinoue S, Ishii Y, Sawada T, Murakami T, Iwadoh K, Sannomiya A, Koyama I, Kubota K, Tojimbara T, Nakajima I, Teraoka S. Fuchinoue S, et al. Transplantation. 2011 Apr 27;91(8):853-7. doi: 10.1097/TP.0b013e31820f08e8. Transplantation. 2011. PMID: 21297552

6

A Clinical Trial With Adoptive Transfer of Ex Vivo-induced, Donor-specific Immune-regulatory Cells in Kidney Transplantation-A Second Report.

Koyama I, Bashuda H, Uchida K, Seino KI, Habu S, Nakajima I, Fuchinoue S, Okumura K, Teraoka S. Koyama I, et al. Among authors: fuchinoue s. Transplantation. 2020 Nov;104(11):2415-2423. doi: 10.1097/TP.0000000000003149. Transplantation. 2020. PMID: 33125206

7

Xenoantigen, an alphaGal epitope-expression construct driven by the hTERT-promoter, specifically kills human pancreatic cancer cell line.

Sawada T, Yamada O, Yoshimura N, Hatori K, Fuchinoue S, Teraoka S. Sawada T, et al. Among authors: fuchinoue s. Cancer Cell Int. 2002 Oct 3;2(1):14. doi: 10.1186/1475-2867-2-14. Cancer Cell Int. 2002. PMID: 12392598 Free PMC article.

8

Living related liver transplantation for polycystic liver disease.

Koyama I, Fuchinoue S, Urashima Y, Kato Y, Tsuji K, Kawase T, Murakami T, Tojimbara T, Nakajima I, Teraoka S. Koyama I, et al. Among authors: fuchinoue s. Transpl Int. 2002 Nov;15(11):578-80. doi: 10.1007/s00147-002-0459-0. Epub 2002 Sep 27. Transpl Int. 2002. PMID: 12461664

9

beta6 integrin is up-regulated in chronic renal allograft dysfunction.

Sawada T, Abe M, Kai K, Kubota K, Fuchinoue S, Teraoka S. Sawada T, et al. Among authors: fuchinoue s. Clin Transplant. 2004 Oct;18(5):525-8. doi: 10.1111/j.1399-0012.2004.00199.x. Clin Transplant. 2004. PMID: 15344954

10

Lobular damage caused by cellular and humoral immunity in liver allograft rejection.

Sawada T, Shimizu A, Kubota K, Fuchinoue S, Teraoka S. Sawada T, et al. Among authors: fuchinoue s. Clin Transplant. 2005 Feb;19(1):110-4. doi: 10.1111/j.1399-0012.2004.00310.x. Clin Transplant. 2005. PMID: 15659143

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

236 results

Search Page

Filters